←
Nick Burwick, MD869 posts
Nick Burwick, MD avatar

Nick Burwick, MD

@NickBurwick

hematologist🤍

◷ Joined June 2020▧ 203 Photos and videos
Jason Ryan avatar
⟳ Nick Burwick, MD retweeted
Jason Ryan@jasonryanmd·Nov 15

Brock Purdy was the last pick in the NFL draft nobody wanted him but he’s a baller. Believe in yourself even when no one else does.

PURDY TO CMC IS MAGICAL

0:20
Nick Burwick, MD avatar
Nick Burwick, MD@NickBurwick·Nov 14

fantastic podcast with Dr Sarah Colonna, Salt Lake City VA. crisp explanations, with a focus on practical solutions and process in the era of genetic medicine in VHA. #VA_CGS

The Research Report episode 3 is now LIVE! 🥼 Join our hosts as they're joined by special guest Dr. Sarah Colonna to discuss the differences in genetic and genomic testing, communicating what it these tests mean with the patient, how AI is evolving the practice space, and what research and career opportunities are available for those looking to work with CGS. Listen on your favorite podcast apps or on the AVAHO Connect app today! 🟣 Apple Podcasts - podcasts.apple.com/us/podcas… 🟢 Spotify - open.spotify.com/show/6PKkBT… #MedicalPodcast #HemOnc #ClinicalResearch

Post attachment
Gaurab Chakrabarti avatar
⟳ Nick Burwick, MD retweeted
Gaurab Chakrabarti@Gaurab·Nov 11

A million people on the full-dose Wegovy pill need about 9.1 tonnes of semaglutide a year. A million people on the weekly shot need about 0.125 tonnes. Novo sold about $811M of Wegovy pills in Q3, up 68% from Q2. A patient who switches from the shot to the full-dose pill goes from 2.4 mg of purified semaglutide a week to 175 mg. Each daily pill contains 25 mg because only 1% to 2% of the semaglutide in it reaches the blood. On bivalirudin, a shorter blood-thinner peptide, Bachem and ChromaCon used a twin-column process to cut the material needed per kilogram of purified peptide from about 5,200 kg to 1,400 kg, and raised yield from 57% to 62%. That is about 4 times better. The pill takes about 73 times more semaglutide per patient. A million people on the pill would need about half of all the GLP-1 peptide the world will use this year.

Nick Burwick, MD avatar
⟳ Nick Burwick, MD retweeted
Nick Burwick, MD@NickBurwick·23 Dec 2025

the United States is the dominant global supplier of plasma, used for IVIG and other products, due to its compensation of donors

Bloomberg@business4 Dec 2025

Medications made with plasma save millions of lives, but the primary source is impoverished Americans who sell their blood—and the long-term health effects are unclear bloomberg.com/news/articles/…

Nick Burwick, MD avatar
Nick Burwick, MD@NickBurwick·Nov 7

meet the new #AVAHO President Grace Cullen 🎙️

On this new episode of the AVAHO Carecast, AVAHO President, Grace Cullen joins us to talk about her 2027 goals as AVAHO President, Nick's experience over the last year as AVAHO Past President, and the importance of strengthening connections in 2027. Listen on your favorite podcast apps or on the AVAHO Connect app! 🟣 Apple Podcasts - podcasts.apple.com/us/podcas… 🟢 Spotify - open.spotify.com/show/4YTPyF… #MedicalPodcast #MedLife #HemOnc

Post attachment
Adam Schefter avatar
⟳ Nick Burwick, MD retweeted
Adam Schefter@AdamSchefter·Oct 29

An estimated 75% of former NFL players who died between 2008 and 2023 had chronic traumatic encephalopathy, or CTE, the neurodegenerative brain disease tied to high-impact sports such as football, according to a new study. espn.com/nfl/story/_/id/5031…

NEJM Clinician avatar
⟳ Nick Burwick, MD retweeted
NEJM Clinician@NEJMClinician·Oct 22

In a Veterans Health Administration study, blast exposure during military service was associated with higher rates of neurologic and systemic diagnoses years later. @MichaelOkun has the context and key results: jwat.ch/4hX95qt

Post attachment
Adam Schefter avatar
⟳ Nick Burwick, MD retweeted
Adam Schefter@AdamSchefter·Oct 23

Pro Football Hall of Fame running back and Southern University coach Marshall Faulk has been diagnosed with Parkinson's disease. Story via @ByScarborough: espn.com/nfl/story/_/id/5025…

Nick Burwick, MD avatar
Nick Burwick, MD@NickBurwick·Oct 17

new podcast series on Avaho Voices ➡️ #better_eating hosted by Taylor Scialo ➡️ first episode out now!

This is Better Eating, a podcast at the intersection of oncology nutrition and Veteran care. Hosted by Taylor Scialo, a registered dietitian specializing in cancer nutrition. Each episode will be joined by experts and advocates working every day to improve how Veterans with cancer eat, recover, and live to the fullest through food and nutrition. Listen to the pilot episode today on the AVAHO Connect app or your favorite podcast platforms! 🟣 Apple Podcasts - podcasts.apple.com/us/podcas… 🟢 Spotify - open.spotify.com/show/5jByxh… #MedicalPodcast #NutritionEducation #HemOnc

Post attachment
KOMO News avatar
⟳ Nick Burwick, MD retweeted
KOMO News@komonews·Oct 16

NBA Expansion to Seattle is "no longer a lock," according to a published report that raises immediate questions about whether the league is trying to generate competition or create leverage to boost the price of a franchise. ESPN’s Brian Windhorst reported Friday that NBA Commissioner Adam Silver “left owners with the impression that a Seattle expansion team was no longer a lock” at the September Board of Governors meeting in New York. The report also suggested that a Mexico City-based group may have caught the league’s attention. Immediate consternation brewed among SuperSonic hopefuls, who have long pined for basketball to return to one of the largest U.S. markets without a franchise. Full story here: bit.ly/4zBuw7u #komo #komo4 #komonews #seattle

1:59
Nick Burwick, MD avatar
Nick Burwick, MD@NickBurwick·Oct 16

the soybean leghemoglobin gene is inserted into the tomato plants, but the heme molecule itself is something tomato plants already make on their own.​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ is that correct? so what makes the tomato red? 🍅

A 17-year-old scientist is creating tomatoes designed to taste like hamburgers Gabriella Rothberg says she's genetically engineering them to produce heme, a molecule used to give plant-based meat its flavor

Post attachmentPost attachment
Nick Burwick, MD avatar
Nick Burwick, MD@NickBurwick·Oct 15

AVAHO roundtable ➡️ check it out as we go around the horn talking MM BsAb therapy within VHA

Our new AVAHO Expert Roundtable on Removing Barriers to Integration of Bispecific Antibodies for Multiple Myeloma in the VA is available to watch on YouTube, the AVAHO Education Center, and the new AVAHO Connect app! Thank you Johnson & Johnson for supporting this AVAHO Expert Roundtable! 🫶 Watch here - youtu.be/NWSzZwjAQcE #MMSM #Myeloma #Sponsored

Post attachment
Gaurab Chakrabarti avatar
⟳ Nick Burwick, MD retweeted
Gaurab Chakrabarti@Gaurab·Oct 14

About 1 in 8 American adults say they take a drug like Ozempic or Zepbound. The first GLP-1 drug, Byetta, was a synthetic copy of a peptide from Gila monster venom. Human GLP-1, the gut hormone that tells the pancreas to release insulin, lasts about 2 minutes in the body. An enzyme called DPP-4 cuts off its first two amino acids, right after the alanine in position 2, and the shortened hormone no longer triggers insulin release. The lizard's peptide has glycine there, and DPP-4 doesn't cut glycine. Its synthetic copy, exenatide, lasts 2.4 hours. John Eng, an endocrinologist at a veterans' hospital in the Bronx, read that Gila monster venom made the pancreas swell. In 1992 he pulled a 39-amino-acid peptide out of that venom. About half its amino acids matched human GLP-1. Eng's employer, the VA, declined to patent it because it wasn't specific to veterans, so he filed the patent himself in 1993. For 3 years, almost every big diabetes drugmaker ignored him or passed. In 1996 Amylin licensed it, and the FDA approved it as Byetta in 2005. Novo Nordisk built Ozempic from human GLP-1, so DPP-4 would cut it too. Ozempic's semaglutide swaps that second alanine for Aib, an amino acid that isn't in human proteins, to protect it from DPP-4. Eli Lilly partnered with Amylin on Byetta from 2002 to 2011. In 2025, Lilly's own GLP-1 drug, tirzepatide (Zepbound and Mounjaro), sold $36.5B and passed Merck's Keytruda as the world's best-selling drug. Lilly ended tirzepatide's chain with amino acids copied from the monster's peptide.

Post attachmentPost attachment
Nick Burwick, MD avatar
Nick Burwick, MD@NickBurwick·Oct 10

Take a listen to our latest episode ➡️ featuring Dr Aditi Singh, Minneapolis VA

On this new episode of the AVAHO Carecast, Dr. Aditi Singh join us to talk about her research interests, the power of mentorship, and her involvement in upcoming AVAHO shows! Listen on your favorite podcast apps or on the AVAHO Connect app! 🟣 Apple Podcasts - podcasts.apple.com/us/podcas… 🟢 Spotify - open.spotify.com/show/4YTPyF… #MedicalPodcast #MedLife #HemOnc

Post attachment